Generate Biomedicines

$1.52B

Generate Biomedicines (NASDAQ: GENB) is a clinical-stage generative biology company founded in 2018 within Flagship Pioneering by Avak Kahvejian, Geoffrey von Maltzahn, Molly Gibson, and Gevorg…

$1.52B last priced transaction (>1yr old) (as of 2021-11)
5 sourced signals across 1 data source

Loading the full interactive profile on VizierAtlas…